Company: Evox Therpaeutics
Job title: Co-Founder & Chief Operating Officer
Dr Per Lundin has over 10 years of experience founding, leading and advising biotech companies developing groundbreaking therapies. Dr Lundin is co-founder of Evox Therapeutics and has acted as the company’s Chief Operating Officer since inception. Prior to Evox, he co-founded and served as CEO of IsletOne Therapeutics, a clinical stage cell therapy company, and he currently serves as non-executive director and board member of the publicly listed gene therapy company Combigene. Dr Lundin has extensive business development experience and is also as an authorised European Patent Attorney. He started his career as a research scientist working on nanoparticle drug delivery. He earned his Ph.D. at the Karolinska Institute, holds an MSc in Biotechnology Engineering, and an MBA.
Panel Discussion: Commercialization, Partnerships & Regulation 3:30 pm
What lessons have the leading companies in the field learned from their collaborations and submissions to date? How can technology choice affect your commercial result? Delving into recent regulatory conversations to inform trial design and, ultimately, maximize market access later in developmentRead more
day: Day Two